Literature DB >> 15172675

Advances in chromatin remodeling and human disease.

Kyoung Sang Cho1, Leah I Elizondo, Cornelius F Boerkoel.   

Abstract

Epigenetic factors alter phenotype without changing genotype. A primary molecular mechanism underlying epigenetics is the alteration of chromatin structure by covalent DNA modifications, covalent histone modifications, and nucleosome reorganization. Remodeling of chromatin structure regulates DNA methylation, replication, recombination, and repair as well as gene expression. As these functions would predict, dysfunction of the proteins that remodel chromatin causes an array of multi-system disorders and neoplasias. Insights from these diseases suggest that during embryonic and fetal life, environmental distortions of chromatin remodeling encode a 'molecular memory' that predispose the individual to diseases in adulthood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15172675     DOI: 10.1016/j.gde.2004.04.015

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  27 in total

Review 1.  Epigenetic regulation of early neural fate commitment.

Authors:  Yunbo Qiao; Xianfa Yang; Naihe Jing
Journal:  Cell Mol Life Sci       Date:  2016-01-22       Impact factor: 9.261

Review 2.  Epigenetics and neural stem cell commitment.

Authors:  Hai-Liang Tang; Jian-Hong Zhu
Journal:  Neurosci Bull       Date:  2007-07       Impact factor: 5.203

Review 3.  Review: DNA methylation and alcohol use disorders: Progress and challenges.

Authors:  Huiping Zhang; Joel Gelernter
Journal:  Am J Addict       Date:  2016-10-19

4.  DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors.

Authors:  Nesrin S Rechache; Yonghong Wang; Holly S Stevenson; J Keith Killian; Daniel C Edelman; Maria Merino; Lisa Zhang; Naris Nilubol; Constantine A Stratakis; Paul S Meltzer; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2012-04-03       Impact factor: 5.958

5.  Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguishes X-linked thrombocytopenia from Wiskott-Aldrich syndrome.

Authors:  Koustav Sarkar; Sanjoy Sadhukhan; Seong-Su Han; Yatin M Vyas
Journal:  Blood       Date:  2014-09-24       Impact factor: 22.113

6.  Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia.

Authors:  Gopalrao V N Velagaleti; Gabriel A Bien-Willner; Jill K Northup; Lillian H Lockhart; Judy C Hawkins; Syed M Jalal; Marjorie Withers; James R Lupski; Pawel Stankiewicz
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

Review 7.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 8.  Chromatin-modifying enzymes as therapeutic targets--Part 2.

Authors:  Brian R Keppler; Trevor K Archer
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

9.  Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions.

Authors:  Ben Davidson; Tian-Li Wang; Ie-Ming Shih; Aasmund Berner
Journal:  Hum Pathol       Date:  2008-03-04       Impact factor: 3.466

10.  Gene clusters, molecular evolution and disease: a speculation.

Authors:  Leah I Elizondo; Paymaan Jafar-Nejad; J Marietta Clewing; Cornelius F Boerkoel
Journal:  Curr Genomics       Date:  2009-03       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.